Certification of a Pilot with Charcot-Marie-Tooth Disease

Area of Science:

• Neurology
• Aviation Medicine
• Regulatory Affairs

Background:

• Charcot-Marie-Tooth disease (CMT) is a rare hereditary motor and sensory neuropathy.
• This report addresses the challenges in medical certification for pilots with neurological disabilities, specifically CMTX1.
• The study focuses on a pilot diagnosed with CMTX1.

Observation:

• The pilot, diagnosed with CMTX1, experienced gradual onset of weakness and muscle wasting in his feet and hands from his mid-forties.
• Despite symptoms, the pilot reported no impact on flying activities.
• Clinical examination suggested potential limitations in performing all commercial pilot tasks, including emergency procedures.

Findings:

• A modified Medical Flight Test (MFT) was developed to assess functional impairments specific to the pilot's condition.
• The tailored MFT allowed for successful medical certification of the pilot.
• This approach demonstrated the feasibility of assessing pilots with rare neurological conditions.

Implications:

• The modified MFT approach offers a viable solution for certifying pilots with rare neurological disabilities.
• This case study provides a framework for aviation regulators to manage medical certification for pilots with CMT and similar conditions.
• It emphasizes the importance of individualized assessments over blanket restrictions for pilots with chronic neurological diseases.